药品注册申请号:214656
申请类型:ANDA (仿制药申请)
申请人:RUBICON
申请人全名:RUBICON RESEARCH PRIVATE LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML No No AA 2022/01/13 2022/01/13 Prescription
002 POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML No No AA 2022/01/13 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2022/01/13 ORIG-1(原始申请) Approval STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:POTASSIUM CHLORIDE 剂型/给药途径:SOLUTION;ORAL 规格:20MEQ/15ML 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
206814 001 NDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription Yes No AA 2014/12/22 GENUS LIFESCIENCES
210041 001 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription No No AA 2018/07/19 AMNEAL
211067 001 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription No No AA 2018/08/08 APOTEX
209786 001 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription No No AA 2018/08/29 NOVEL LABS INC
210766 001 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription No No AA 2019/03/29 PHARM ASSOC
213392 001 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription No No AA 2021/01/29 GRANULES
211648 001 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription No No AA 2021/05/21 SCIEGEN PHARMS INC
214656 001 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription No No AA 2022/01/13 RUBICON
213062 001 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription No No AA 2022/06/06 WES PHARMA INC
214892 001 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription No No AA 2022/12/30 ANDA REPOSITORY
216156 001 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription No No AA 2023/03/07 BELCHER
211665 002 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 20MEQ/15ML Prescription No No AA 2024/01/16 STRIDES PHARMA
活性成分:POTASSIUM CHLORIDE 剂型/给药途径:SOLUTION;ORAL 规格:40MEQ/15ML 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
206814 002 NDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Prescription Yes Yes AA 2014/12/22 GENUS LIFESCIENCES
210041 002 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Prescription No No AA 2018/07/19 AMNEAL
211067 002 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Prescription No No AA 2018/08/08 APOTEX
209786 002 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Prescription No No AA 2018/08/29 NOVEL LABS INC
210766 002 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Prescription No No AA 2019/03/29 PHARM ASSOC
213392 002 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Prescription No No AA 2021/01/29 GRANULES
211648 002 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Prescription No No AA 2021/05/21 SCIEGEN PHARMS INC
214656 002 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Prescription No No AA 2022/01/13 RUBICON
213062 002 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Prescription No No AA 2022/06/06 WES PHARMA INC
211665 001 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Discontinued No No AA 2022/11/17 STRIDES PHARMA
214892 002 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Prescription No No AA 2022/12/30 ANDA REPOSITORY
216156 002 ANDA POTASSIUM CHLORIDE POTASSIUM CHLORIDE SOLUTION;ORAL 40MEQ/15ML Prescription No No AA 2023/03/07 BELCHER
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database